| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 220.02 | 5.4% | 9.2% |
| Total Income | 222.11 | 5.5% | 9.7% |
| Expenditure | 216.46 | 5.3% | 15.6% |
| PBT | 5.65 | 11.7% | 62.8% |
| Net Profit | 3.69 | 9.5% | 63.1% |
| OPM | 14.50% | 0.14pp | 17.69pp |
| NPM | 1.66% | 0.06pp | 3.24pp |
| EPS | 1.40 | 9.4% | 63.2% |
Neogen Chemicals Reports 9% YoY Revenue Growth in Q3 FY26, Despite Fire Incident Costs
12 Feb 2026 · 12 Feb, 5:31 am
Summary
Neogen Chemicals Limited reported stable financial performance for the third quarter and nine months ending 31st December, 2025. In Q3 FY26 (consolidated), revenues stood at INR 220 crore, higher by 9% YoY, despite Dahej capacity bottlenecks. EBITDA for Q3 FY26 (consolidated) stood at INR 32 crore, though Y-o-Y comparisons reflect transitory cost headwinds. Neogen’s profit after tax for Q3 FY26 (consolidated) stood at INR 4 crore. Performance at a Glance INR crore (Standalone) Q3 FY26 YoY Growth Revenues 216 > 8% Gross Profit 99 > 8% EBITDA 36 yb 4% PAT 9 ab 39% INR crore (Consolidated) Q3 FY26 YoY Growth Revenues 220 ~> 9% Gross Profit 104 > 13% EBITDA 32 8% PAT 4 63%
Key Highlights
- 1
9% YoY revenue growth in Q3 FY26
- 2
Dahej capacity bottlenecks mitigated through toll manufacturing arrangements
- 3
Neogen lonics (NIL) Q3 FY26 revenue stood at INR 12 crore
- 4
EBITDA for Q3 FY26 stood at INR 32 crore
- 5
Profitability impacted due to post-fire operating and insurance costs
- 6
Higher interest costs for growth and plant reconstruction also impacted profitability
- 7
Construction of the replacement plant progressing rapidly, with commissioning scheduled for Q1 FY27
- 8
The Board has granted in-principle approval to raise up to INR 150 crore through a preferential issue of equity shares to the Promoter Group
Management Comments
Dr. Harin Kanani
Managing Director, Neogen Chemicals
Our Q3 FY26 performance reflects a steady recovery and a strategic pivot toward a future-ready portfolio. In our base business, we continue to see strong resilience across non-agchem applications, specifically Pharma, F&F and more. This demand stability, combined with our product optimization initiatives and upcoming replacement plant in Dahej, ensures our core operations remain robust despite global market transitions. In Battery Materials, we have reached a transformative phase. As several Indian gigawatt players launch capacities later this and next financial year, Neogen is positioned as the most cost-efficient lithium salt and electrolyte source with proven Japanese technologies. The non-FEOC requirement for 45X tax credit in U.S. and current substantial price increase in China remains a substantial tailwind as we expand our global footprint in lithium salt. We anticipate several large-scale customers finalizing approvals for our lithium salts, leading to bulk consignments by H1 FY27. Operationally, the Greenfield Pakhajan Electrolyte plant is nearing mechanical completion. The specialized MUIS technology equipment has arrived at our site and assembly is currently underway. As we transition into regular, long-term supply agreements, we are confident that Neogen lonics will become the cornerstone of our growth, reinforcing our position as a technology-led leader in the global battery chemicals value chain.
Informational and educational content only. Not investment advice.